Completed OBSERVATIONAL NCT01210209

Study of Blood Samples From Patients With Ewing Sarcoma and Their Relatives (GENEWING)

GENEWING - A Genome Wide Association Study in Ewing Sarcoma

Sponsor: Institut Curie

Conditions Sarcoma

Interventions genome-wide association study

Updated 8 times since 2017 Last updated: May 18, 2021 Started: Jan 7, 2010 Primary completion: Jul 31, 2019 Completion: Jul 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Sarcoma and is currently completed. Institut Curie leads this study, which shows 8 recorded versions since 2010 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jun 2021 — Jul 2024 [monthly]

Completed
Mar 2021 — Jun 2021 [monthly]

Completed

Status: Unknown Status → Completed
Jan 2021 — Mar 2021 [monthly]

Unknown Status

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institut Curie

Data source: Institut Curie

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France